| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Camilla V Simpson is Director at SPRB. Camilla V Simpson's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider.
Camilla V Simpson has 13 Form 4 filings on record from April 2021 to May 2026, across 2 companies: Director at Spruce Biosciences (SPRB), 2021–2026; Director at GRI Bio (GRI), 2023–2025.
The 25 reported transactions were 16 option or other derivative awards, 5 dispositions back to the company, 2 option exercises and 2 open-market sales.
Counted by filing, the open-market trades come to no purchases and 2 sales worth about $232K.
The largest open-market sale was 14,045 shares of SPRB at an average $16.14 on April 30, 2021, about $227K. Twelve months later SPRB was down 89%.